DOI: https://doi.org/10.14710/jbtr.v10i2.21211

Revealing the Potency of Camelia sinensis and Serenoa repens as Purinoreceptor Inhibitor for Benign Prostatic Hyperplasia Treatment through in Silico Study

1General Practitioner of Public Health Center of Kunir, Indonesia

2Department of Urology, Faculty of Medicine, Universitas Brawijaya, Indonesia

Received: 6 Dec 2023; Accepted: 13 Aug 2024; Available online: 30 Aug 2024; Published: 30 Aug 2024.
Open Access Copyright (c) 2024 Journal of Biomedicine and Translational Research
Creative Commons License This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Citation Format:
Abstract

Background: Benign prostatic hyperplasia (BPH) is the most common prostate disease in elderly men that leads to a significant deterioration in patients' quality of life (QoL). Pharmacological therapy of 5-alpha reductase inhibitor and alpha adrenoreceptors blocker often causes several side effects that decrease the QoL, so it is necessary to develop a new treatment for BPH. Purinoreceptor is a novel receptor that can inhibit electrically evoked nerve-mediated contractions in the prostate. Tea leaves (Camellia sinensis) and Saw palmetto (Serenoa repens) are herbs that have potential as alternative therapies for BPH

Objective: to reveal the mechanism of Camellia sinensis and Serenoa repens through purinoreceptor and the other receptors

Methods: Structures of active compounds were extracted from PubChem and protein from PBD. The active compounds Camellia sinensis and Serenoa repens to the target protein purinoreceptors, 5-alpha-reductase, and alpha adrenoreceptors was evaluated in silico using a docking server with Finasteride dan Tamsolusin as a control. Molecular docking method using dockingserver application.

Results: Epigallocatechin gallate only compound that has potency in blocking purinoceptors and 5-alpha-reductase. Capric acid, Caprylic acid, Lauric acid, Linoleic acid, and Myristic acid have the potential to bind to alpha adrenoreceptor ligands.

Conclusion: Camellia sinensis have potential and effects as alternative therapies in benign prostatic hyperplasia on the target protein purinoreceptors, 5-alpha-reductase, and alpha adrenoreceptors. But, Serenoa repens have potential only through alpha adrenoreceptors.

Note: This article has supplementary file(s).

Fulltext View|Download |  Cover Letter
Cover letter
Subject
Type Cover Letter
  Download (28KB)    Indexing metadata
Keywords: Camellia sinensis, Serenoa repens, Benign prostatic hyperplasia, In silico, Purinoreceptor

Article Metrics:

Article Info
Section: Original Research Articles
Language : EN
Recent articles
Revealing the Potency of Camelia sinensis and Serenoa repens as Purinoreceptor Inhibitor for Benign Prostatic Hyperplasia Treatment through in Silico Study The Effect of Sambiloto (Andrographis paniculata) Leaf Extract in Combination with Phosphomycin on The Germ Number, Urine Leukocyte Esterase, and Urine Procalcitonin Levels in Wistar Rats (Rattus norvegicus) Urinary Tract Infection Model Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios are Predictors of Lung Malignancy More recent articles
  1. Lim KB. Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017 Jul;4(3):148-151. doi: 10.1016/j.ajur.2017.06.004.Epub2017Jun9.PMID:29264223;PMCID:PMC5717991
  2. Patel ND, Parsons JK. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol. 2014 Apr;30(2):170-6. doi: 10.4103/0970-1591.126900.PMID:24744516;PMCID:PMC3989819
  3. Lokeshwar SD, Harper BT, Webb E, Jordan A, Dykes TA, Neal DE Jr, Terris MK, Klaassen Z. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. Transl Androl Urol. 2019 Oct;8(5):529-539. doi: 10.21037/tau.2019.10.01.PMID:31807429;PMCID:PMC6842780
  4. Lerner LB, McVary, KT, Barry MJ et al: Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline part I, initial work-up and medical management. J Urol 2021; 206: 806
  5. Ventura S, Oliver Vl, White CW, Xie JH, Haynes JM, Exintaris B. Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH). Br J Pharmacol. 2011 Jul;163(5):891-907. doi: 10.1111/j.1476-5381.2011.01332.x.PMID:21410684;PMCID:PMC3130937
  6. Ford AP, Gever JR, Nunn PA, Zhong Y, Cefalu JS, Dillon MP, Cockayne DA. Purinoceptors as therapeutic targets for lower urinary tract dysfunction. Br J Pharmacol. 2006 Feb;147 Suppl 2(Suppl 2):S132-43. doi: 10.1038/sj.bjp.0706637.PMID:16465177;PMCID:PMC1751490
  7. Jadid N, Kurniawan E, Himayani CES, Andriyani, Prasetyowati I, Purwani KI, Muslihatin W, Hidayati D, Tjahjaningrum ITD. An ethnobotanical study of medicinal plants used by the Tengger tribe in Ngadisari village, Indonesia. PLoS One. 2020 Jul 13;15(7):e0235886. doi: 10.1371/journal.pone.0235886.PMID:32658902;PMCID:PMC7357767
  8. Katz A, Efros M, Kaminetsky J, Herrlinger K, Chirouzes D, Ceddia M. A green and black tea extract benefits urological health in men with lower urinary tract symptoms. Ther Adv Urol. 2014 Jun;6(3):89-96. doi: 10.1177/1756287214526924.PMID:24883106;PMCID:PMC4003843
  9. Putra MMR, Seputra KP. The Potential of Cammelia sinensis (Tea Leaves) Active Compound as Alternative Therapy on castrate-resistant prostate cancer (CRPC) with Androgen Receptor Inhibition: In Silico Study. BHSJ [Internet]. 2022 Apr. 28 [cited 2022 Jun. 27];5(1):25-8. Available from: https://www.e-journal.unair.ac.id/BHSJ/article/view/32147
  10. Koch W, Zagórska J, Marzec Z, Kukula-Koch W. Applications of Tea (Camellia sinensis) and its Active Constituents in Cosmetics. Molecules. 2019 Nov 24;24(23):4277. doi: 10.3390/molecules24234277.PMID:31771249;PMCID:PMC6930595
  11. Chua T, Eise NT, Simpson JS, Ventura S. Pharmacological characterization and chemical fractionation of a liposterolic extract of saw palmetto (Serenoa repens): effects on rat prostate contractility. J Ethnopharmacol. 2014 Mar 14;152(2):283-91. doi: 10.1016/j.jep.2013.12.030.Epub2014Jan21.PMID:24463033
  12. Damayanti, D. S., Utomo, D. H., and Kusuma, C, 2017. Revealing the potency of Annona muricata leaves extract as FOXO1 inhibitor for diabetes mellitus treatment through computational study. In Silico Pharmacology, 5(1)
  13. Gilson, M. K., and Zhou, H. X, 2007. Calculation of protein-ligand binding affinities. Annu Rev Biophys Biomol Struct 36:21–42
  14. Tambunan US, Alamudi S. 2010. Designing cyclic peptide inhibitor of dengue virus NS3-NS2B protease by using molecular docking approach. Bioinformation. 5(6):250-254
  15. Mardianingrum, R., Herlina, T & Supratman, U. Isolasi dan Molecular docking senyawa 6,7-dihidro17-hidroksierisotrin dari daun dadap belendung (Erythrina poppigiana) terhadap aktivitas sitotoksik antikanker payudara MCF-7. Chimica et Natura Acta. 2015. 3(3): 90–93
  16. Bikadi, Z. and Hazai, E. 2009. “Application of the PM6 semiempirical method to modeling proteins enhances docking accuracy of AutoDock”. Journal of Cheminformatics. 1(15)
  17. Mubarika, S.A.Z., Dewi, A.R., and Damayanti D.Sri, 2019. In Silico Study: Anthelmintic Potential of Garlic’s Active Compound (Allium sativum L.) by inhibiting Acetylcholinesterase, Beta tubulin and activate Voltage dependent L type Calcium Channel. Faculty of Medicine University of Islam Malang. 83-93
  18. Ventura, S., Oliver, V. l., White, C. W., Xie, J. H., Haynes, J. M., and Exintaris, B, 2011. Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH). British journal of pharmacology, 163(5), 891–907
  19. North, R Alan, and Michael F Jarvis. “P2X receptors as drug targets.” Molecular pharmacology vol. 83,4 (2013): 759-69. doi: 10.1124/mol.112.083758
  20. Alsufyani, H. A., & Docherty, J. R. (2021). Roles for α1-adrenoceptors during contractions by electrical field stimulation in mouse vas deferens. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology, 25(6), 525–532. https://doi.org/10.4196/kjpp.2021.25.6.525
  21. Batty, M., Pugh, R., Rathinam, I., Simmonds, J., Walker, E., Forbes, A., Anoopkumar-Dukie, S., McDermott, C. M., Spencer, B., Christie, D., & Chess-Williams, R. (2016). The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers. International journal of molecular sciences, 17(8), 1339. https://doi.org/10.3390/ijms17081339
  22. H. Purnomo, M. Tegar, A. E. Nugroho. 2013. Interaksi Senyawa Aktif dari Aegle marmelos Correa sebagai Anti Inflamasi dengan Reseptor COX1 dan COX-2. Traditional Medicine Journal. Vol.18:80-87
  23. Leibacher, Nathan Walter, Marcelo Henrique Araujo da Silva. The adverse Effect of Tamsulosin in Men With Benign Prostatic Hyperplasia, A Review of the Literatur. American Journal of life science. 2019 ; 7 (4). 68-74
  24. Dunn, C. J., Matheson, A., and Faulds, D. M, 2002. Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. Drugs & aging, 19(2)
  25. Du, X., Li, Y., Xia, Y. L., Ai, S. M., Liang, J., Sang, P., Ji, X. L., dan Liu, S. Q, 2016. Insights into Protein-Ligand Interactions: Mechanisms, Models, and Methods. International journal of molecular sciences, 17(2), 144

Last update:

No citation recorded.

Last update:

No citation recorded.